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Global prevalence of obesity has increased to epidemic proportions over the past 40 years, with 
childhood obesity reaching alarming rates. In this study, we determined changes in liver and adipose 
tissue transcriptomes of a porcine model for prepubertal early obesity induced by a high-calorie diet 
and supplemented with bioactive ingredients. A total of 43 nine-weeks-old animals distributed in four 
pens were fed with four different dietary treatments for 10 weeks: a conventional diet; a western-type 
diet; and a western-type diet with Bifidobacterium breve and rice hydrolysate, either adding or not 
omega-3 fatty acids. Animals fed a western-type diet increased body weight and total fat content and 
exhibited elevated serum concentrations of cholesterol, whereas animals supplemented with bioactive 
ingredients showed lower body weight gain and tended to accumulate less fat. An RNA-seq experiment 
was performed with a total of 20 animals (five per group). Differential expression analyses revealed an 
increase in lipogenesis, cholesterogenesis and inflammatory processes in animals on the western-type 
diet while the supplementation with bioactive ingredients induced fatty acid oxidation and cholesterol 
catabolism, and decreased adipogenesis and inflammation. These results reveal molecular mechanisms 
underlying the beneficial effects of bioactive ingredient supplementation in an obese pig model.
Obesity is characterized by the excessive accumulation of adipose tissue and its association with many metabolic 
abnormalities, including (but no limited to) insulin resistance, development of type 2 diabetes, cardiovascular 
diseases, and cancer1. Childhood obesity, favoured by an obesogenic environment, is reaching alarming rates 
with the major health threat of developing chronic illness as adults. Accordingly, the Commission on Ending 
Childhood Obesity developed in 2016 a package of recommendations to prevent and treat childhood obesity 
mainly focused on dietary education and the promotion of physical activity. At the individual level, adjunct 
approaches such as pharmacotherapy or bariatric surgery have been developed, and the incorporation of bioac-
tive ingredients in the diet has proven effective for the obesity treatment.
Studies in rodent animal models evidenced the anti-obesity beneficial properties of probiotic administration 
(reviewed in2). The supplementation of Bifidobacterium breve B-3 in high-fat-diet (HFD)-induced obese mice 
has been shown to suppress body gain weight and epididymal fat deposition, and to improve serum levels of 
total cholesterol, glucose and insulin3. Expression analyses performed in this mouse model disclosed that the 
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administration of Bifidobacterium breve B-3 modified the hepatic expression of genes related to lipid metabolism 
and response to stress4. A reduction in body fat has been also observed in healthy pre-obese individuals receiving 
Bifidobacterium breve B-3, but no significant improvement of blood parameters was found5. In partial agreement, 
studies with rodent models of obesity have demonstrated the anti-obesity effect of n-3 polyunsaturated fatty acids 
(PUFA). Reduction of fat mass was predominantly observed in mice fed a HFD and supplemented with n-3 PUFA 
(reviewed in6). However, the effects of n-3 PUFA in human obesity remain inconclusive. On the other hand, rice 
proteins and their hydrolysates added to high fat and/or high cholesterol diets have shown to have anti-obesity 
and hypocholesterolemic effects through the effective modulation of cholesterol and triglyceride metabolism, and 
the activity of hepatic genes related to lipid metabolism7,8.
Overall, these experimental evidences reinforce the relevance of using bioactive dietetic supplements to pre-
vent and treat obesity. However, as most of these studies were performed in rodent models, the underlying biolog-
ical mechanisms determining anti-obesity effects are difficult to translate into humans, due to the vast differences 
between these species at the physiological and metabolic level9. In contrast, pigs are excellent models for human 
obesity and its comorbidities, given their similarity in terms of anatomy, physiology, metabolism, and genetics9–11.
To date, a limited number of pig models for childhood obesity have been developed by short term (≤ 12 wk.) 
dietary interventions of high-fat-regimes in young pigs9,12,13. These models seem to develop early features of 
childhood obesity without developing insulin resistance or metabolic syndrome. In a previous work, a porcine 
model of prepubertal early obesity induced by a high-calorie diet was characterized at the phenotypic level14. 
Here, we studied the transcriptomic changes in relevant metabolic tissues derived from both feeding a high calo-
rie diet and supplementing with bioactive ingredients, including Bifidobacterium breve, rice hydrolysate, and n-3 
PUFA, in piglets of this porcine model of prepubertal early obesity. The final aim was to determine the molecular 
mechanisms and biological processes underlying the beneficial effects of bioactive ingredient supplementation in 
a porcine model for childhood obesity.
Results
Phenotypic differences between piglets feeding different diets and bioactive ingredients. 
Data regarding growth, feed/energy intake, and biochemical variables in piglets subjected to the four dietary 
treatments is shown in Table 1. All groups of piglets had similar body weight at the beginning of the experiment 
(week 9). During the two months of dietary treatment, animals fed a western-type diet without supplementation 
showed the highest weight gain, reaching a body weight above piglets fed a balanced diet (60.0 kg in T2 vs. 53.3 kg 
in T1 at week 18). Conversely, piglets supplemented with Bifidobacterium breve probiotic and rice hydrolysate 
(T3 and T4) showed a significantly attenuated weight gain with respect to T2 animals, and reached final weights 
(51.4 and 50.2 kg at week 18, respectively) close to the control group. In terms of energy intake, all three groups of 
animals fed western-type diet (T2, T3 and T4) had a calorie ingestion (kcal/day) significantly superior to animals 
in the control group (T1).
Besides, important differences regarding body composition were observed between animals in different 
dietary treatments. The mean percentage of fat estimated through computed tomography (relative fat volume) 
increased from 12.7% in piglets with a balanced diet to 19.3% in piglets fed the western-type diet. This increase 
in adiposity derived from high calorie intake applied to all fat depots (i.e. subcutaneous, intermuscular, and flare 
fat), but particularly to the subcutaneous depot (8.4% in T1 vs 13.2% in T2, P < 0.0001). Regarding the supple-
mentation with Bifidobacterium breve probiotic, animals in T3 and T4 also showed an increased adiposity when 
compared to the control group (T1), but the relative amount of fat in all compartments tended to be lower than 
in no supplemented piglets (T2).
Serum lipid levels run relatively in parallel to differences observed in fat deposition. Serum concentrations of 
total cholesterol and both LDL- and HDL-cholesterol, as well as concentrations of triglycerides, were higher in 
piglets with a high calorie intake, either with or without bioactive supplementation (T2, T3 and T4), than in the 
control group (T1), although some of the comparisons did not reach statistical significance. To be noted, animals 
fed on T4 showed significant lower levels of LDL-cholesterol in serum than their T2 counterparts.
transcriptomic changes induced by a high calorie diet. To study the effect of a high calorie diet 
on gene expression, the transcriptomes of liver and two different adipose tissue depots: visceral adipose tissue 
(VAT) and subcutaneous adipose tissue (SAT), belonging to two groups of piglets fed control (T1; n = 5) and 
western-type (T2; n = 5) diets were analyzed by RNA-seq. First, we performed principal-component analysis 
(PCA) of RNA-seq data, identifying an outlier in the control group of SAT (Supplementary Fig. S1) that was 
removed before further analyses.
Differential expression analyses showed 11 genes differentially expressed (DE) in liver between T1 and T2 
piglets (Supplementary Table S1). Most of these DE genes, 9 out of 11, were upregulated in the T2 piglets under 
the high calorie regime (Fig. 1A). Histamine Receptor H1 (HRH1) was the most upregulated gene (FC = 20.77, 
P-value = 4.41 × 10−06), while 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 (HMGCS2) was the most downreg-
ulated gene in the T2 fed animals (FC−1 = 4.26, P-value = 2.40 × 10−05).
Regarding transcriptomic changes in adipose tissue, no DE genes were found in VAT, whereas 171 genes DE 
between T1 and T2 piglets were identified in SAT (Supplementary Table S2). Of these, 100 genes were upregu-
lated and 71 were downregulated in the T2 fed animals (Fig. 1B,C) when compared to the control (T1) group. The 
genes most up- and downregulated in the T2 fed group were Myosin Heavy Chain 4 (MYH4; FC = 614.29, P-value 
= 8.72 × 10−07) and Iroquois Homeobox 1 (IRX1; FC−1 = 10.04, P-value = 1.47 × 10−04), respectively.
To gain a better understanding of the biological processes and pathways involved in the response to the high 
calorie diet, a functional annotation of DE genes in liver and SAT was performed. In liver, the only significant 
enriched network identified by IPA and containing all the DE genes between T1 and T2 was associated with car-
bohydrate metabolism, lipid metabolism and molecular transport (Fig. 2A). Accordingly, the biological functions 
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most significantly enriched in the list of DE genes were related to the accumulation of carbohydrate, concentra-
tion of triacylglycerol, hormone, lipid and D-glucose, and production of ketone body among others (Fig. 2C). 
The full list of biological functions identified is shown in Supplementary Table S3. Finally, among the list of 
canonical pathways overrepresented, it is worth to highlight PXR/RXR activation with Cytochrome P450 Family 
2 Subfamily B Member 6 (CYP2B6), HMGCS2, and ATP Binding Cassette Subfamily C Member 3 (ABCC3) as 
components.
More noteworthy, we identified thirteen networks (Supplementary Table S4) significantly overrepresented 
in the set of DE genes in SAT. The top network was related with lipid metabolism, molecular transport and 
small molecule biochemistry (Fig. 2B). Furthermore, the top fourth network was associated with endocrine sys-
tem development and function, lipid metabolism and small molecule biochemistry, with the Leptin (LEP) gene, 
upregulated in T2 compared with T1 (FC  =  1.81, P-value = 3.43 × 10− 4), taking part of most of the functions 
identified for this network. The list of biological functions annotated by IPA is shown in Supplementary Table S5. 
Among these biological functions, it is relevant to highlight several functions with a z-score greater than 2, which 
indicates an increase of the activation state of these biological functions in T2: recruitment of phagocytes (z-score 
= 2.820), synthesis of lipid (z-score = 2.002) and fatty acid metabolism (z-core = 2.273) (Fig. 2D). Finally, among 
the most significantly enriched canonical pathways in the list of DE genes in SAT (Supplementary Table S6), it is 
worth mentioning the clathrin-mediated endocytosis signaling, ILK signaling, complement system, aldosterone 
signaling in epithelial cells, NRF2-mediated oxidative stress response, insulin receptor signaling and AMPK sig-
naling pathways (Fig. 2E).
Upstream regulators of gene expression induced by a high calorie diet. Retinoid X Receptor 
Alpha (RXRA) and Peroxisome Proliferator Activated Receptor Alpha (PPARA) were the top upstream regulators 
identified in liver. RXRA directly interacts with six DE genes (Fig. 2A). PPARA heterodimerizes with the nuclear 
receptor RXR and plays a pivotal role in fatty acid catabolism15. In SAT, Sterol Regulatory Element Binding 
Transcription Factors 1 and 2 (SREBP1 and SREBP2) were the top upstream transcription regulators. These 
transcription regulators are involved in sterol and fatty acid biosynthesis16. Remarkably, while in SAT SREBF1 
(z-score = 2.097) and SREBF2 (z-score = 2.562) were activated in T2 compared to T1, PPARA in liver presented 
a negative z-score (−1.359).
Transcriptomic changes produced in liver and adipose depots of animals fed a western-type 
diet supplemented with bioactive ingredients. The transcriptomes of liver, VAT and SAT of the two 
groups of piglets fed a western diet plus bioactive supplementation (T3 and T4; n = 5 each) were also analysed 
by RNAseq to study the effect at gene expression level of adding different bioactive ingredients in a high calorie 
diet. Together with Bifidobacterium breve probiotic supplementation, 50% of protein of animal origin in T2 was 
replaced by vegetal protein in T3 and T4 groups. Animals in T4 were also supplemented with omega-3 fatty acids.
VARIABLE SIGN1
LSmeans by treatment2
T1 T2 T3 T4
Body weight at week 9 (kg) n.s. 16.50a 16.70a 16.14a 16.27a
Body weight at week 18 (kg) * 53.27a 60.00b 51.36a 50.23a
Average daily weight gain (kg) ** 0.58ab 0.69b 0.56a 0.54a
Average daily feed intake (kg) ** 1.46a 1.42ab 1.31ab 1.26b
Average daily calorie intake (kcal) **** 3819.75a 5213.93b 4876.75b 4693.72b
Liver weight (gr) n.s. 1336.18a 1518.90a 1431.73a 1385.45a
Weight of flare fat (gr) **** 188.73a 405.30b 354.27b 323.73b
Percentage of fat (%) **** 12.66a 19.35b 17.91b 17.74b
Percentage of subcutaneous fat (%) **** 8.36a 13.20b 12.42b 12.00b
Percentage of intermuscular fat (%) * 1.27a 1.84b 1.52ab 1.53ab
Percentage of flare fat (%) *** 3.03a 4.32b 3.98b 3.89b
Total cholesterol in serum (mg/dl) * 125.90a 155.74ab 167.16b 144.19ab
HDL-cholesterol in serum (mg/dl) *** 45.25a 61.36b 68.91b 59.10b
LDL-cholesterol in serum (mg/dl) * 46.87a 57.11b 51.13ab 45.33a
Triglycerides in serum (mg/dl) *** 21.67a 29.22ab 33.42b 25.15a
Glucose in serum (mg/dl) n.s.+ 89.20a 108.54a 117.80a 119.78a
Fructosamine in serum (μmol/dl) n.s. 177.61a 152.14a 179.50a 165.97a
Table 1. Significance of dietary treatment effect on piglets weight, growth, feed/calorie intake, fat deposition 
and biochemical variables, plus least square means (LSmeans) within each treatment: control diet (T1); western-
type diet (T2); western-type diet with rice protein and supplemented with probiotic (T3); western-type diet 
with rice protein and supplemented with probiotic and omega-3 fatty acids (T4). 1SIGN - Significance of dietary 
treatment effect according to its p-value in a one-way analysis of variance: ****P < 0.0001; *** P< 0.001; 
**P < 0.01; *P < 0.05; +P < 0.1; n.s. no significant. 2Different superindex (a and b) indicates significant 
differences (P < 0.05) between LSmeans in a Tukey’s HSD test for multiple comparisons.
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A total of 30 genes were identified as DE in liver between T2 and T3 fed piglets, 17 upregulated and 13 down-
regulated in the T3 group when compared to the T2 group (Fig. 3A and Supplementary Table S7). Remarkably, 
the genes most up- and downregulated in T3 were Fibroblast Growth Factor 21 (FGF21; FC = 14.63, P-value = 
1.41 × 10−07) and Serine Dehydratase (SDS; FC−1 = 17.45, P-value = 4.19 × 10−06), respectively.
In relation to adipose tissue, no genes DE between T2 and T3 groups were identified in VAT, similarly to 
previous T2vsT1 comparison. In SAT, the comparison between T2 and T3 diets reported the largest number of 
DE genes among all comparisons between dietary treatments, suggesting a vast effect of adding the probiotic 
plus the vegetal-origin protein on the SAT transcriptome. A total of 1818 DE genes were identified (Fig. 3B and 
Supplementary Table S8). Most of these DE genes, 1237 out of 1818, showed higher expression levels in T3 piglets, 
being DIRAS Family GTPase 3 (DIRAS3) the most upregulated gene in this group (FC = 129.93, P-value = 7.02 
× 10−38). In contrast, only 581 genes showed higher expression in T2 (vs T3) piglets, with three homeobox genes 
among the top upregulated genes in T2: Homeobox A10 (HOXA10; FC−1 = 364.69, P-value = 8.04 × 10−60), 
Homeobox C10 (HOXC10; FC−1 = 147.0, P-value = 1.05 × 10−21) and Homeobox A9 (HOXA9; FC−1 = 33.48, 
P-value = 1.71×10−113).
The functional annotation revealed that the top biological network enriched by the list of genes DE in liver 
was associated with carbohydrate metabolism, molecular transport and small molecule biochemistry (Fig. 4A). 
FGF21 was central in this network, and was interconnected with molecules such as insulin, carbohydrate or cho-
lesterol. The other network identified was associated with cellular movement, hematological system development 
and function, and immune cell trafficking. Finally, a significantly enriched group of DE genes (ABCC3, EPHX1, 
SLC51B) upregulated in the T3 group was identified as associated with the KEGG pathway bile secretion.
In SAT, a total of 25 networks were identified (Supplementary Table S9) as overrepresented in the list of DE 
genes. Among the top ten networks, it is noteworthy the presence of diseases and functions related to connec-
tive tissue disorders, amino acid metabolism, carbohydrate metabolism, endocrine system disorder, metabolic 
Figure 1. Differentially expressed (DE) genes in liver and subcutaneous adipose tissue (SAT) between T1 and 
T2 fed animals. Volcano plot displaying DE genes in liver (A) and SAT (B) between T1 and T2 treatments. 
The vertical axis (y-axis) corresponds to the −log10 (P-value), and the horizontal axis (x-axis) displays the log2 
fold change (logFC) value. Green dots represent DE genes according to a FDR < 0.05 and |logFC| > 1. Red 
dots represent DE genes according to a FDR < 0.05 and |logFC| > 0.58 and orange dots represent DE genes 
according to a FDR < 0.05. Positive x-values represent genes upregulated and negative x-values represent 
genes downregulated in T2vsT1 groups. The vertical dashed lines mark the |logFC| = 1. C) Heatmap of the 
171 DE genes between T1 and T2 treatments in SAT. Each row represents a gene (n = 171) and each column 
represents an individual (n = 9). Line graphs on top of the heatmap show clustering of the samples in T1 (blue) 
and T2 (pink) treatments based on the pattern of gene expression. The color scale represents changes of gene 
expression: blue boxes represent genes downregulated and red and orange boxes represent genes upregulated.
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disease, cell signaling, and developmental processes (Fig. 4B). In addition, we identified a total of 35 canonical 
pathways with a z-score greater than 2 (activation state increased in T3 or decreased in T2) and two canonical 
pathways with a negative z-score lower than −2 (Fig. 4C and Supplementary Table S10). Among the canonical 
pathways with a positive z-core, it is worth to highlight GP6 signaling pathway, STAT3 pathway and IL-6, IL-8 and 
NF-kB signaling among others. The antioxidant action of vitamin C and PPAR signaling pathways have a negative 
Figure 2. Functional categorization of differentially expressed (DE) genes in liver and subcutaneous adipose 
tissue (SAT) between T1 and T2 fed animals using the Core Analysis function included in the Ingenuity 
Pathway Analysis (IPA) software. Plots of the biological networks most significantly enriched by the list of DE 
genes between T1 and T2 fed animals in (A) liver: Carbohydrate metabolism, Lipid metabolism and Molecular 
transport and (B) SAT: Lipid metabolism, Molecular transport and Small molecule biochemistry. Red color 
indicates genes upregulated and green color downregulated in T2vsT1 groups. Top biological functions in liver 
(C) and activated biological functions in SAT (D) sorted by their P-values identified by the list of DE genes 
between T1 and T2 treatments. Threshold (grey horizontal dashed line) indicates the minimum significance 
level based on the Fisher exact test with a –log10 (P-value) > 1.3 (P-value < 0.05). Color indicates the activation 
state, orange for positive z-score > 2 (activation state increased in T2vsT1) and blue for negative z-score < −2 
(activation state decreased in T2vsT1). E) Top canonical pathways identified by the list of DE genes in SAT 
between T1 and T2 treatments sorted by their P-values. Threshold (grey horizontal dashed line) indicates the 
minimum significance level based on the Fisher exact test with a –log10 (P-value) > 1.3 (P-value < 0.05). Ratio 
indicates the number of DE genes from the dataset that map to the pathway divided by the total number of 
genes that define the canonical pathway. Color indicates the activation state.
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z-score. Moreover, we identified with Cluego highly significant reactome pathways such as extracellular matrix 
organization, degradation of the extracellular matrix and collagen formation; GO biological processes such as 
blood vessel development and angiogenesis, and KEGG pathways such as PI3K-Akt signaling pathway, enriched 
with genes upregulated in the T3 group.
Comparison between T2 and T4 diets only revealed 12 DE genes in liver (Fig. 5A and Supplementary 
Table S11), many of which were common with those identified when comparing T2 and T3 diets, including 
FGF21 (FC = 15.45, P-value = 3.88 × 10−07).
Nor was any DE gene found in VAT, but we identified 1318 genes whose expression in SAT differed between 
T2 and T4 groups (Fig. 5B and Supplementary Table S12). As occurred in liver, most of these genes (1167 out of 
1318) were also found to be DE in SAT between T2 and T3 (Fig. 5C).
As regards functional annotation of DE genes in liver, only one overrepresented pathway related to energy 
production, lipid metabolism and small molecule biochemistry was identified (Supplementary Fig. S2). In SAT, 
considering that there was a vast number of DE genes commonly identified in the T3vsT2 and T4vsT2 compari-
sons, it was not surprising to identify common networks at functional annotation level.
Given the similarity between transcriptomic changes observed in both T3vsT2 and T4vsT2 comparisons, 
additional DE analyses between T3 and T4 were performed to better assess changes in the expression profile 
derived from incorporating omega-3 fatty acids to the supplementation with probiotic and rice hydrolysate. 
Results showed a low impact on both liver and SAT transcriptomes, with only one gene identified as DE in each 
tissue (PNPLA3 and LCE3C were downregulated in liver and SAT, respectively, of T4 fed animals).
Upstream regulators of gene expression induced by bioactive ingredients. Activating 
Transcription Factor 4 (ATF4) was identified as upstream regulator of genes DE in liver. Remarkably, this tran-
scriptional factor is activated in T3 compared to T2 (z-score = 1.986), regulating the expression of Asparagine 
Synthetase (Glutamine-Hydrolyzing) (ASNS), Activating Transcription Factor 5 (ATF5), ChaC Glutathione 
Specific Gamma-Glutamylcyclotransferase 1 (CHAC1) and FGF21. Also, we identified the Transcription Factor 
7 Like 2 (TCF7L2) in the T3vsT2 comparison, with the following target genes: Ectonucleoside Triphosphate 
Diphosphohydrolase 5 (inactive) (ENTPD5), FGF21, Malic Enzyme 1 (ME1) and myosin VI (MYO6). TCF7L2 
has been implicated in blood glucose homeostasis and in the type 2 diabetes disease risk17.
In SAT, the most significant upstream regulators identified were the Transforming Growth Factor Beta 
1 (TGFB1; with the highest z-score > 6.5), Transforming Growth Factor Beta 2 (TGFB2; z-score > 3) and 
Transforming Growth Factor Beta 3 (TGFB3; z-score > 3.2), the latter also upregulated in both T3 and T4 piglets 
when compared with T2 animals. These growth factors inhibit adipogenesis and regulates ECM protein expres-
sion through the induction of collagens and fibronectin and the repression of MMPs18,19. In addition, another 
transcription factor that was found activated in T3 and T4 animals was the Signal Transducer and Activator 
of Transcription 3 (STAT3; z-score > 2). This transcription factor is key in the interleukin 10 (IL10) mediated 
anti-inflammatory response20.
qpcR validation of RnA-seq data. Seven genes representatives of key pathways identified by the RNA-seq 
analysis were analysed by quantitative real-time PCR (qPCR) to validate the RNA-seq results: ABCC3, GCK, and 
FGF21 genes in liver, and COL2A1, DIRAS3, IL10 and LEP in SAT. When the pattern of gene expression levels 
was compared, high correlations were observed between qPCR and RNA-seq, ranging from 0.730 to 0.995 in liver 
and 0.609 to 0.986 in SAT, which confirmed a high reproducibility of the data. Furthermore, when the RQ mean 
values were compared between diets, most gene expression differences previously detected by RNA-seq were 
validated (Supplementary Fig. S3).
Figure 3. Volcano plots of differentially expressed (DE) genes between T2 and T3 fed animals in (A) liver and 
(B) subcutaneous adipose tissue (SAT). The vertical axis (y-axis) corresponds to the −log10 (P-value), and the 
horizontal axis (x-axis) displays the log2 fold change (logFC) value. Green dots represent DE genes according 
to a FDR < 0.05 in liver and FDR < 0.01 in SAT and |logFC| > 1. Red dots represent DE genes according to a 
FDR < 0.05 in liver and FDR < 0.01 in SAT and |logFC| > 0.58 and orange dots represent DE genes according 
to a FDR < 0.05 in liver and FDR < 0.01 in SAT. Positive x-values represent genes upregulated and negative 
x-values represent genes downregulated in T3vsT2 groups. The vertical dashed lines mark the |logFC| = 1.
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Figure 4. Functional categorization of differentially expressed (DE) genes in liver and subcutaneous adipose 
tissue (SAT) between T2 and T3 fed animals using the Core Analysis function included in the Ingenuity 
Pathway Analysis (IPA) software. (A) Plot of the biological network most significantly enriched by the list of DE 
genes between T2 and T3 fed animals in liver: Carbohydrate metabolism, Molecular transport and Small molecule 
biochemistry. Red color indicates genes downregulated and green color upregulated in T3vsT2 groups and (B) 
Top 10 biological networks most significantly enriched by the list of DE genes between T2 and T3 fed animals 
in SAT. The vertical axis (y-axis) corresponds to the diseases and functions enriched in the top ten networks. 
The horizontal axis (x-axis) displays the network score and the orange vertical line the focus molecules. (C) 
Canonical pathways sorted by their P-values identified by the list of DE genes between T2 and T3 treatments 
in SAT. Threshold indicates the minimum significance level based on the Fisher exact test with a −log10 
(P-value) > 1.3 (P-value < 0.05). Ratio indicates the number of DE genes from the dataset that map to the 
pathway divided by the total number of genes that define the canonical pathway. Color indicates the activation 
state, orange for positive z-score > 2 (activation state increased in T3vsT2) and blue for negative z-score < −2 
(activation state decreased in T3vsT2).
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Discussion
The development of effective strategies to prevent childhood obesity and its comorbidities requires a better under-
standing of this condition. The research of transcript-based biomarkers represents a powerful tool in the identifi-
cation of mechanisms of relevance in the control of obesity21–23 and the impact exercised by different treatments.
The transcriptomes of metabolic relevant tissues from our porcine model of prepubertal obesity pointed that 
SAT was the tissue showing most relevant changes at transcriptomic level (largest number of DE genes) in all 
comparisons, whereas no changes in the expression profile of VAT were observed. Unlike VAT, SAT grows and 
differentiates very quickly from birth becoming the main fat depot in swine24. While SAT is used as a measure 
of general adiposity in pigs and contributes to overall metabolism, VAT accumulation has been associated with 
an increased pathological risk25,26. However, an independent role for SAT in insulin resistance has been sug-
gested27,28, indicating that SAT is also a good predictor of metabolic risk and insulin resistance29. In keeping with 
these observations, the increase in adiposity after 10 weeks of high calorie intake was particularly relevant in the 
SAT depot, which could explain the transcriptional changes observed in SAT but not in VAT of animals fed with 
a western-type diet compared to animals fed a control diet.
The top networks involved in transcriptomic changes derived from a high-calorie diet in both liver and SAT 
tissues were related with carbohydrate metabolism, lipid metabolism, molecular transport, and small molecule 
biochemistry. Nonetheless, a network related with endocrine system development and function, in which the 
LEP gene was playing a relevant role, was identified in SAT. LEP is a circulating hormone produced by the adi-
pose tissue that regulates energy homeostasis and whose overexpression has been described in different adipose 
depots of obese individuals30. In accordance, LEP gene was upregulated in the western-diet fed animals together 
with other genes (ACLY and ACSS2) related with an increase of lipid synthesis or fatty acid metabolism biolog-
ical functions. Deletion of these genes in animal models protects against hepatic steatosis, fat deposition, obe-
sity and attenuates atherosclerosis31,32. Other genes related with concentration and transport of cholesterol and 
sterol synthesis were also upregulated in animals fed a T2 diet (ADM, LDLR, MSR1, NPC1, STARD4 and TRIB1). 
Figure 5. Differentially expressed (DE) genes in liver and subcutaneous adipose tissue (SAT) between T2 and 
T4 fed animals. Volcano plot displaying DE genes in liver (A) and SAT (B) between T2 and T4 treatments. 
The vertical axis (y-axis) corresponds to the -log10 (P-value), and the horizontal axis (x-axis) displays the log2 
fold change (logFC) value. Green dots represent DE genes according to a FDR < 0.05 and |logFC| > 1. Red 
dots represent DE genes according to a FDR < 0.05 and |logFC| > 0.58 and orange dots represent DE genes 
according to a FDR < 0.05. Positive x-values represent genes upregulated and negative x-values represent genes 
downregulated in T4vsT2 groups. The vertical dashed lines mark the |logFC| = 1. (C) Heatmap of common 
differentially expressed genes found in SAT between T3vsT2 and T4vsT2 treatments. Each row represents a 
gene (n = 1167) and each column represents an individual (n = 15). Line graphs on top of the heatmap show 
clustering of the samples in T2 (pink) and between T3 and T4 (green and blue, respectively) treatments based 
on the pattern of gene expression. Note that the individuals of the T3 and T4 treatments were not clustered 
separately according to the treatment. The color scale represents changes of gene expression: blue boxes 
represent genes downregulated and red and orange boxes represent genes upregulated.
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Dysregulation of most of these genes has been associated with fat deposition and obesity in different species33–36, 
being also involved in endothelial dysfunction and atherosclerosis37,38. On the contrary, we identified the Growth 
Factor Receptor Bound Protein 10 (GRB10) gene downregulated in the western-diet fed animals. GRB10 has been 
proposed as an important regulator of adipose tissue metabolism and energy homeostasis through the regulation 
of PI3K/Akt/mTORC1 signaling39. The fat specific disruption of this gene increased fat mass and obesity via sup-
pressing mTORC1-mediated lipolysis in adipose tissues39.
Biological functions related with recruitment of macrophages and phagocytes but also leukocytes, neutrophils 
and myeloid cells were also activated in pigs on western diet. The development of atherosclerosis and insulin 
resistance in obesity has been directly linked to the activation of proinflammatory pathways in adipose tissue with 
macrophage infiltration contributing to this proinflammatory state40,41. In line with these results, we identified 
the CD68 molecule (CD68) gene upregulated in animals on the western diet. CD68 is a macrophage-associated 
antigen that correlated positively with adipocyte size and body mass in humans and presented high expression 
levels in human subcutaneous adipose tissue of obese individuals42. Furthermore, the gene AGT encoding angi-
otensinogen was upregulated in the western-diet fed group. Increased adipose angiotensinogen gene expression 
in obesity43 has been associated with the etiology of endothelial dysfunction12. Other genes (CD163 and LYZ) 
related with inflammatory processes were also overexpressed in western-diet fed pigs. LYZ has been involved in 
the development of atherosclerosis in a juvenile obesity pig model44. Finally, it is worth mentioning the canonical 
pathway “complement system” composed of five molecules (ITGB2, C4BPA, C1QC, C1QA, C1QB) upregulated 
in animals on the western diet. Adipose expression of C1q complement was increased in obese individuals, sug-
gesting that classic pathway activation may play an important role in adipose tissue inflammation and insulin 
resistance45. The Complement C3 (C3) gene was also among the genes upregulated in the western-diet fed group. 
The increased production of C3 in adipose tissue may lead to both increased infiltration of macrophages and 
stimulated triglyceride synthesis in adipose tissue, thus contributing to insulin resistance and atherosclerosis46,47.
In liver, four genes related with the metabolism of carbohydrate function were upregulated in western-fed 
animals (HRH1, GCK, DIO2 and PPP1R3C) compared with control ones. A metabolic crosstalk between gly-
cogen and lipogenesis was demonstrated in mice fed with a HFD; the overexpression of Protein Phosphatase 1 
Regulatory Subunit 3C (PPP1R3C, also known as PTG) dramatically augmented the hepatic accumulation of gly-
cogen which shifted energy storage from glycogen to lipid through the increased expression of lipogenic genes48. 
Furthermore, the product of DIO2 gene activates thyroid hormone (TH) which increases fatty acid uptake in the 
liver and hepatic lipogenesis49. Some authors suggest that TH may promote the synthesis of HDL49, which in turn 
may explain the high HDL cholesterol levels in serum of western-fed pigs.
On the other hand, the most downregulated gene in the liver of animals fed a high-calorie diet was HMGCS2. 
The protein codified by this gene is a mitochondrial enzyme that catalyses the first reaction of ketogenesis to pro-
vide with energy extrahepatic tissues in periods of carbohydrate deprivation such as fasting50. The higher levels 
of energy supplied to pigs fed a western-type diet (3621 kcal/kg) compared with pigs fed a control diet (2587 kcal/
kg) suggest that, in the first group, the energy is directed towards the metabolic pathways of glycogenesis, de novo 
lipogenesis and cholesterogenesis with a decrease in ketogenesis.
Switches in the liver expression profile derived from feeding an HFD affected also genes related with 
whole-body cholesterol homeostasis. In physiological conditions, cholesterol is excreted by the liver either by 
secreting it into bile or by converting it into bile acids, the end products of cholesterol catabolism51,52. To this 
regard, we identified as upregulated in the western-fed animals different genes related with the conversion of cho-
lesterol to bile acids (CYP2B6), taurine conjugation of bile acids (CDO1) and export of bile acids from hepatocytes 
(ABCC3). Additionally, the NPC1 Like Intracellular Cholesterol Transporter 1 (NPC1L1) gene was downregu-
lated in this western-diet fed group. NPC1L1 localizes to the canalicular membrane of hepatocytes and facilitates 
the biliary cholesterol re-uptake into hepatocytes53. These results suggest an increased biliary cholesterol secretion 
and cholesterol catabolism in animals fed a western-type diet that may explain the lack of differences between 
cholesterol concentrations between T2 and T1 fed groups and the increased faecal fat content observed in the 
animals on the western-type diet (T1 = 19.5 ± 1.3 mg/g vs T2 = 50 ± 8 mg/g).
Taken together, our findings suggest an increased lipogenesis, cholesterogenesis and decreased lipolysis in 
animals on the western diet, which contributed to raise fat content and triggered inflammatory processes through 
the activation of the complement system and the recruitment of immune cells such as macrophages. All these 
processes could be involved in the development of endothelial dysfunction and insulin resistance and later on 
could trigger metabolic syndrome.
After studying the transcriptional changes produced in our pig model of diet-induced prepubertal obesity, we 
examined the effect of adding different bioactive ingredients to animals under a western-type diet. At phenotypic 
level, animals supplemented with Bifidobacterium breve probiotic and rice hydrolysate (with or without omega-3 
PUFA) showed lower body weight gain and a suggestive tendency to lower fat content than no supplemented 
(T2) pigs feeding the same HFD. Similar results have been previously reported in other HFD-animal models 
supplemented with similar bioactive components2,3,6–8. The supplementation with Bifidobacterium breve probiotic 
plus rice hydrolysate did not improve significantly the serum levels of total cholesterol and triglycerides, but pigs 
additionally supplemented with omega 3 showed a decrease in the serum levels of LDL.
These phenotypic differences were also accompanied by changes in the transcriptional profiles of liver and SAT 
tissues of the supplemented animals, with the largest number of DE genes observed in animals fed with the pro-
biotic Bifidobacterium breve plus rice hydrolysate (diet T3). The addition of omega 3 supplementation (T4vsT3) 
produced a negligible variation in the expression profile of both liver and SAT, which suggests that incorporating 
omega-3 fatty acids beyond the Bifidobacterium breve probiotic and rice hydrolysate supplementation has a low 
modulation effect on both liver and SAT transcriptomes. Considering these results, in the following section we 
only discuss the role of DE genes and biological processes involved in the response to the supplementation with 
Bifidobacterium breve probiotic and rice hydrolysate. In addition, since the T3 and T4 treatments contain more 
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than one bioactive ingredient, further analysis is needed to elucidate whether transcriptional changes occur due 
to the specific effect of an ingredient or the interaction among them.
Supplementation with bioactive ingredients produced a high impact on the transcriptomic profile of 
SAT, where we identified the greatest number of DE genes and functions when comparing supplemented vs 
non-supplemented HFD early obese piglets. The most upregulated gene was the DIRAS3 gene, whose expression 
levels increased till ~130 folds in animals receiving Bifidobacterium breve probiotic plus rice hydrolysate. This 
gene has been identified as upregulated in adipose-derived stromal/progenitor cells in SAT of long-term weight 
losing initially obese human females, in which DIRAS3 gene reduced adipogenesis and activated autophagy 
through the negative regulation of Akt-mTOR signalling54. In line with this result, genes involved in the induction 
of adipogenesis pathway55 (BMP5, BMP7, CEBPA and ZNF521) were identified (either up- or down-regulated) in 
animals fed on western diet while genes (BMP2 and RUNX2) that favour MSCs differentiation into osteoblasts vs 
adipogenic commitment56 resulted upregulated in the supplemented pigs.
We observed also an overrepresentation of pathways related with vascular and ECM remodelling: GP6 sig-
nalling pathway, extracellular matrix organization, degradation of extracellular matrix and collagen formation, 
blood vessel development and angiogenesis. These pathways gather genes, upregulated in supplemented ani-
mals, that encode collagen proteins (COL2A1, COL8A2, COL11A2, COL8A1, COL11A1, COL12A1, COL1A2, 
COL1A1, COL21A1, COL16A1, COL28A1, COL6A6, COL14A1, COL6A3, COL6A5, COL6A2, COL6A1, 
COL4A5, COL3A1, COL5A1) and other ECM components (CYR61, CTGF, MMP2, MMP16, MMP17, NOV, 
SPARC, TIMP1, TIMP2, THBS1, THBS2, THBS3 and THBS4). Furthermore, angiogenic factors such as VEGFD 
or ANGPTLs (ANGPTL1, ANGPTL2, ANGPTL5) growth factors were upregulated in the supplemented dietary 
treatments.
Although over-expression of proteins related to ECM remodelling has been associated with exacerbated fibro-
sis and metabolic alterations in obese individuals, there are also studies supporting beneficial effects of adipose 
tissue fibrosis19,55. In fact, up-regulation of ECM components has been also observed in individuals after bari-
atric surgery57,58 or experiencing weight loss during very low-calorie diet29. Therefore, the reduction in adipose 
accumulation observed in animals supplemented with Bifidobacterium breve probiotic plus rice hydrolysate may 
be accompanied by intense extracellular matrix remodelling to favour adequate plasticity and expandability of 
adipose tissue. However, histopathology studies are needed to better understand the role of ECM remodelling in 
adipose tissue of animals supplemented with Bifidobacterium breve and rice hydrolysate.
Weight loss in obese subjects has been also associated with decreased expression of inflammatory markers 
joined with the concomitant up-regulation of anti-inflammatory cytokines such as Interleukin 10 (IL10)29. IL10 is 
a major immunosuppressive cytokine, and together with STAT3 is essential for the anti-inflammatory response20. 
Transgenic mice with muscle-specific overexpression of IL10 were more insulin sensitive and protected from 
HFD-induced inflammatory response in muscle59. Here, we found the IL10 gene and its receptor (IL10RA) upreg-
ulated in HFD piglets receiving the T3 diet, probably indicating an improvement of the inflammatory profile of 
SAT in obese animals derived from the ingestion of these bioactive ingredients. In close support with our view, 
other genes with anti-inflammatory effects such as TNF alpha induced protein 6 (TNFAIP6)60 and TNF alpha 
induced protein 3 (TNFAIP3)61 were also identified as upregulated in supplemented piglets.
Finally, it is worth noting the huge down-regulation of several homeobox genes (particularly HOXA10 and 
HOXC10) in SAT derived from bioactive supplementation. A cohort of recent studies have demonstrated a role 
of HOX genes in the regulation of body fat distribution and the origin of obesity (reviewed in62). However, higher 
expression of HOX genes have been shown in lean individuals compared to obese people62 or in individuals after 
a bariatric surgery58; although it is unclear the mechanisms underlying these expression changes.
The gene most upregulated in the liver of piglets supplemented with Bifidobacterium breve and rice hydro-
lysate was the FGF21 gene, whose expression levels were ~15 folds higher in these animals than in western-fed but 
no supplemented animals (T2). Remarkably, this gene has been extensively reported to counteract obesity and its 
comorbidities in many animal models63,64, emerging as a promising therapeutic agent for the treatment of obesity 
and insulin resistance65. FGF21 is a peptide hormone and is primarily secreted by the liver. In this tissue FGF21 
gene functions as a starvation signal inducing gluconeogenesis, fat oxidation and ketogenesis66. The up-regulation 
of FGF21 was accompanied by the up-regulation of ATF5 and ASNS, all genes regulated by the transcription fac-
tor ATF4. It is worth mentioning that similar results have previously been observed in a hepatic knockout mouse 
for CREP (also known as Protein Phosphatase 1 Regulatory Subunit 15B). This gene is a subunit of the eIF2α 
phosphatase complex, a central component of the integrated stress response (ISR) signalling. Its hepatic knockout 
leads to upregulated activity of the downstream ISR signalling protein, ATF4 and its target genes ASNS, ATF5 and 
FGF21. Additional results based on further knockout mice models suggested that liver activation of IRS may be 
a viable target to treat obesity through the upregulation of FGF2167,68. Finally, three genes associated with lipid 
and bile acid secretion (ABCC3, EPHX1, SLC51B) were upregulated in T3 fed pigs when compared to animals on 
the non-supplemented western-type diet. Up-regulation of Solute Carrier Family 51 Beta Subunit (SLC51B; also 
called OSTβ) in human and rodent livers has been associated with a protective role under cholestatic conditions69.
Taken together, our findings suggest an increased anti-inflammatory response, vascular and ECM remodel-
ling and decreased lipogenesis in SAT of animals supplemented with Bifidobacterium breve and rice hydrolysate. 
Furthermore, our results are in accordance with the induction of fatty acid oxidation and excretion of faecal lipid, 
total cholesterol and bile acid in liver, as previously described in rodent models fed HFD and supplemented with 
either hydrolysates of rice protein7 or Bifidobacterium breve B-34.
In conclusion, the present study demonstrates that the western-type diet induces changes in the expression of 
genes related to lipid and cholesterol metabolism, immunity and inflammation in our pig model of prepubertal 
obesity. In addition, our findings show that the supplementation of HFD-induced obese piglets with different 
bioactive ingredients (Bifidobacterium breve and rice hydrolysate) modulates genes and pathways implicated in 
catabolic processes, cholesterol metabolism, adipogenesis, inflammation and ECM remodelling (Fig. 6). These 
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results corroborate some of the previously published results in murine models of obesity supplemented with 
these bioactive ingredients, and shed new light in the molecular mechanisms modified by them in the liver and 
SAT tissues of HFD-induced obese pigs. Finally, we have identified DE genes that might be used as biomarkers to 
improve childhood obesity and its associated comorbidities.
Methods
Experimental device (animals, treatments, growth monitoring and biochemical analyses). 
Animals used for this study belonged to a high intramuscular fat commercial Duroc pig line. The experiment 
was carried out with 48 contemporary female piglets born in 12 different litters (i.e. 12 groups of 4 littermates). 
After weaning (~4 weeks of age), these 48 piglets were transferred to the IRTA pig experimental farm in Monells 
(Girona, Spain), housed in transition devices and fed ad libitum a standard transition diet. At ~9 weeks of age 
animals were assigned to four dietary treatments (10 to 11 animals per treatment) and distributed in four dif-
ferent pens located in environmentally monitored facilities. Each sibling from a litter was assigned to a different 
treatment, so that piglets in one pen were full sibs of piglets in other pen. During the following 10 weeks animals 
were fed ad libitum four different diets (T1 to T4): T1) a conventional (and balanced) growth diet according to 
NRC (Nutrition Resource Centre) recommendations; T2) a western-type diet formulated with a high fat content 
and protein of animal origin (caseinate); T3) a western-type diet in which 50% of the protein was substituted 
by protein of vegetal origin (rice hydrolysate) and soft cheese including 5 × 1010 cfu/day Bifidobacterium breve 
probiotic (CECT8242); and T4) similar to T3 but adding omega-3 fatty acids to the diet (1 g stearidonic acid and 
2 g docosahexaenoic acid per 100 g fat). Experimental diets were elaborated at the IRTA experimental mill in 
Mas de Bover (Tarragona, Spain); details about components and nutritive composition of diets are reported in 
Supplementary Tables S13 and S14, respectively.
For growth monitoring, all pigs were weighed individually at the beginning and every two weeks during the whole 
experiment, plus the day before slaughtering. Individual feed intake was also recorded by means of electronic feeders 
located in each pen (IVO-station feeder; INSENTEC®, The Netherlands). Computed tomography (CT) was used to 
obtain one axial image at the level of the 2nd lumbar vertebrae from all pigs at ~18 weeks of age. The CT-scanning 
of pigs was performed under anesthesia and after 16 h fasting, using the General Electric HiSpeed ZX/I (General 
Electric, Fairfield, CN, USA) equipment. Image analyses were performed with the software VisualPork. Image pro-
cessing allowed transforming the areas of interest into volumes (mm3) of different fat depots according to70, thus 
obtaining estimates of the relative fat volume and the relative amount of subcutaneous, intermuscular and flare fat.
When animals reached 19 weeks of age, they were slaughtered at IRTA experimental slaughterhouse in totally 
controlled conditions and in compliance with all welfare regulations. Blood samples for biochemical analyses 
were taken from overnight fasted animals immediately before sacrifice. After serum separation by centrifuga-
tion, lipids and other conventional biochemical variables, including total cholesterol, LDL cholesterol, HDL 
cholesterol, triglycerides and glucose, were measured by using commercial kits from Spinreact (Girona, Spain). 
Samples of approximately 1 g from liver, visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) 
were collected immediately after slaughter, submerged in RNA-later (Sigma, Spain) and stored at −80 °C after 
24 h, according to the protocols recommended by the manufacturer.
All experimental procedures with pigs, including management, anesthetizing, monitoring, blood sampling 
and slaughtering, were performed according to the Spanish Policy for Animal Protection RD1201/05, which 
meets the European Union Directive 86/609 about the protection of animals used in experimentation. The exper-
imental protocol was approved by the Ethical Committee of the Institut de Recerca i Tecnologia Agroalimentàries 
(IRTA).
Finally, the dietary treatment effects on piglet’s weight, growth, feed/calorie intake, fat deposition and bio-
chemical variables were assessed by a one-way analysis of variance, and differences between the corresponding 
least square means were tested by a Tukey’s HSD test for multiple comparisons.
Figure 6. Overview of the main metabolic pathways up and down-regulated in liver and subcutaneous adipose 
tissue (SAT) of HFD-induced obese piglets supplemented with Bifidobacterium breve and rice hydrolysate. This 
figure was created using images provided by Smart Servier Medical Art.
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mRnA sequencing and RnA-seq data analysis. Total RNA was isolated from liver (n = 20, five animals 
per treatment), visceral adipose tissue (VAT; n = 20) and subcutaneous adipose tissue (SAT; n = 20) samples using 
the Ambion RiboPure (Thermo Fisher Scientific). RNA was quantified in a Nanodrop ND-1000 spectrophotom-
eter and RNA purity and integrity was checked by using a Bioanalyzer-2100 equipment (Agilent Technologies, 
INC., Santa Clara, CA). Libraries were prepared using the TruSeq RNA Sample Preparation Kit (Ilumina Inc., 
CA) and were paired-end sequenced (2 × 75 bp), by using the TruSeq SBS Kit v3-HS (Illumina Inc., CA), in a 
HiSeq. 2000 platform (Illumina Inc., CA). More than 30 M PE reads were obtained for all samples. All sequencing 
tasks were carried out in the Centro Nacional de Análisis Genómico (Barcelona, Spain).
The quality of the raw sequenced reads in the FASTQ files was analysed with the FASTQC software (Babraham 
Bioinformatics, http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Reads were mapped to the refer-
ence pig genome Sscrofa11.1 and the annotation database Ensembl Genes 92 (http://www.ensembl.org/info/data/
ftp/index.html) by using STAR v. 2.5.3a71. Transcript quantification was performed with RSEM v. 1.3.072. The R 
package EdgeR73 was used to identify differentially expressed (DE) genes based on the RNA-seq data. Genes with 
a Fold Change (FC) above 1.5 (i.e. |log2FC| > 0.58) and FDR < 0.05 after correcting for multiple testing were 
classified as DE.
The R package pheatmap and the R VolcanoPlot function were used to graphically represent the expression 
level and significance of DE genes among treatments.
functional analysis. Prior to perform functional analyses, orthologous human gene names, from the list 
of DE genes with a FC above 2 (i.e. |log2FC| > 1) and FDR < 0.05, were retrieved from the Ensembl Genes 92 
Database using the Biomart software74. ClueGO v. 2.3.5 plug-in of Cytoscape v. 3.2.175 and the Core Analysis 
function included in the Ingenuity Pathway Analysis software were used to obtain gene ontologies (GO), biolog-
ical functions, gene networks and canonical pathways significantly (padj < 0.05) enriched in the set of DE genes. 
Activation z-scores greater than 2 or lower than −2 were considered to infer the activation states (increased and 
decreased, respectively) of functional annotations.
Validation of differentially expressed genes by RT-qPCR. A quantitative real-time PCR (qPCR) assay 
using SYBR Green chemistry (SYBRTM Select Master Mix, Applied Biosystems) was performed to validate the 
results obtained by RNA-Seq. The isolated RNA of individual samples for liver and SAT tissues from T1, T2, 
T3 and T4 treatments was reverse-transcribed into cDNA using the PrimeScript RT Reagent Kit (TAKARA) 
in a total volume of 20 μl containing 1 μg for liver or 500 ng for SAT of total RNA, following the manufactur-
er’s instructions. All target-primers, except for the IL10 gene76, were designed using PrimerExpress 2.0 software 
(Applied Biosystems) and are shown in Supplementary Table S15. The ACTB and HPRT1 genes were used as 
endogenous controls77. All assays were tested and PCR efficiencies were evaluated by performing standard curves 
with a four-fold dilutions series (1/4, 1/16, 1/64, 1/256, 1/1024) per triplicate of a pool of 5 cDNA samples in an 
Applied Biosystems 7500 Real-Time PCR System (Applied Biosystems, Inc.; Foster City, CA). A dissociation 
curve was drawn for each primer pair to assess for the specificity of the reactions. A QuantStudio™ 12 K Flex 
Real-Time PCR System (Thermo Fisher Scientific) was used for mRNA quantification. The reactions were carried 
out in a 384-well plate in 15 μl volume containing 3.75 μl of cDNA sample diluted 1/20. Primer concentration 
is reported in Supplementary Table S15. The thermal cycle was: 10 min at 95 °C, 40 cycles of 15 sec at 95 °C and 
1 min at 60 °C. Each sample was analysed in duplicate. Data was analysed using the Thermo Fisher Cloud software 
(Applied Biosystems) and the comparative Ct method78. A sample from an animal fed with the western-diet (T2) 
was selected as calibrator. Correlation coefficients between RNA-seq and qPCR data (RQ) as well as group mean 
comparison test were computed with R.
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